Home › Investigational drug increases PFS in patients with advanced breast cancer
 

Keywords :   


Investigational drug increases PFS in patients with advanced breast cancer

2014-12-17 14:34:20| Biotech - Topix.net

In a groundbreaking study that offers new hope for women with advanced breast cancer, researchers from UCLA's Jonsson Comprehensive Cancer Center have published final clinical trial results that showed the amount of time patients were on treatment without their cancer worsening was effectively doubled in women with advanced breast cancer who took the experimental drug palbociclib. An investigational drug discovered and being developed by Pfizer Inc., palbociclib targets a key family of proteins responsible for cell growth by preventing them from dividing.

Tags: advanced drug cancer increases

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 2
29.06Tropical Storm Beryl Public Advisory Number 2
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 2
29.06Tropical Storm Beryl Forecast Advisory Number 2
More »